Aditum launches Celexor with autoimmune drug from Acelyrin partner Inmagene
21 Sep 2023 //
ENDPTS
Lilly Completes Acquisition of Versanis Bio
14 Aug 2023 //
PR NEWSWIRE
Versanis Bio to Present New Data at American Diabetes Association 83rd Sessions
23 Jun 2023 //
PR NEWSWIRE
Versanis Announces Initiation of BELIEVE Global Phase 2b Study of Bimagrumab
12 Jan 2023 //
PR NEWSWIRE
Versanis Presents Preclinical Data Demonstrating the Potential of Bimagrumab
02 Nov 2022 //
PRNEWSWIRE
Versanis Bio Announces Leadership and Board Appointments
20 Jul 2022 //
PRNEWSWIRE